More interestingly, studies have shown that inhibiting the NF-κB cascade in microglia reduces microgliosis and diet-induced weight gain [4, 9] and restores hypothalamic leptin sensitivity [10], suggesting a promising therapeutic target for HFD-induced obesity. The gene discussed is NFKB1; the disease is obesity due to melanocortin 4 receptor deficiency.